Changes in Cardiac Varices and Their Clinical Significance after Eradication of Esophageal Varices by Band Ligation
Table 2
Baseline characteristics of patients with GOV1s—arranged according to the changes in cardiac varices after eradication of esophageal varices by endoscopic band ligation.
Patients with disappearance of cardiac varices ()
Patients with persistent cardiac varices ()
Age
0.295
Male, (%)
44 (80.0)
25 (83.3)
0.707
Etiology, (%)
0.711
Hepatitis B virus
23 (41.8)
9 (30.9)
Hepatitis C virus
4 (7.3)
2 (6.7)
Alcohol
21 (38.2)
15 (50.0)
Others
7 (12.7)
4 (13.3)
Purpose of EBL, (%)
0.643
Primary prophylaxis
34 (61.8)
17 (56.7)
Secondary prophylaxis
21 (38.2)
13 (43.3)
Size of EVs
0.235
F2
44 (80.0)
27 (90.0)
F3
11 (20.0)
3 (10.0)
Red color sign on EVs, (%)
54 (98.2)
28 (93.3)
0.247
Size of cardiac varices, cm
0.046
Number of EBL sessions
0.226
Number of used rubber bands
0.342
Duration until EVs eradiation, months
0.105
Red color sign on cardiac varices, (%)
1 (1.8)
1 (3.3)
0.660
Platelet count, ×109/L
0.716
INR
0.265
AST, IU/L
0.255
ALT, IU/L
0.157
Bilirubin, mg/dL
0.075
Albumin, g/dL
0.557
Creatinine, mg/dL
0.428
Sodium, mEq/L
0.971
Ascites, (%)
29 (52.7)
20 (66.7)
0.214
HE, (%)
5 (9.1)
4 (13.3)
0.544
Child-Pugh score
0.242
Child-Pugh classification, (%)
0.647
Grade A
24 (43.6)
10 (33.3)
Grade B
26 (47.3)
17 (56.7)
Grade C
5 (9.1)
3 (10.0)
AST: aspartate aminotransferase; ALT: alanine aminotransferase; EBL: endoscopic band ligation; EVs: esophageal varices; GOVs: gastroesophageal varices; INR: international normalized ratio.
